ArticleInternational journal of cardiology. Cardiovascular risk and prevention2026
Association of coffee consumption with diabetes mellitus and gestational diabetes mellitus.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of Coffee Consumption on Fructose-Related Metabolic Alterations: Potential Mechanisms and Implications for Metabolic Diseases.Diseases (Basel, Switzerland) · 2026Review
- Comment on "Association of coffee consumption with diabetes mellitus and gestational diabetes mellitus".International journal of cardiology. Cardiovascular risk and prevention · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To investigate the association of caffeinated and decaffeinated coffee consumption with the risk of diabetes mellitus and gestational diabetes mellitus (GDM). Methods: This is a cross-sectional study included 6311 women(1313 with diabetes mellitus, 574 with GDM) using NHANES data (2007-2018). Logistic regression models were used to evaluate the associations between coffee/caffeine intake and diabetes mellitus/GDM risk. Subgroup analyses were done to test results robustness. Results: Higher caffeinated coffee intake was associated with a decreased risk of diabetes mellitus, with ORs of 0.80 (95%CI, 0.66-0.99) for ≤1 cup/day, 0.73 (95%CI, 0.60-0.88) for 1-2 cups/day, 0.86 (95%CI, 0.69-1.07) for 2-3 cups/day, and 0.74 (95%CI, 0.57-0.96) for >3 cups/day. There were dose-response associations of caffeine consumption and the risk of diabetes mellitus. Stratified analyses highlighted obvious relationships of higher caffeine intake with decreased diabetes mellitus in individuals with a BMI ≥30 kg/m Conclusions: Coffee consumption, particularly caffeinated coffee, is associated with a decreased risk of diabetes mellitus but not with GDM. These findings suggest potential metabolic benefits of coffee.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.